# Omega 3 Fatty Acid Trial

> **NCT00586222** · PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 19 (actual)

## Conditions studied

- Omega-3 Fatty Acids
- Pediatric Bipolar Disorder
- Adolescent Bipolar Disorder
- Magnetic Resonance Spectroscopy Imaging

## Interventions

- **DIETARY_SUPPLEMENT:** Omega-3 Fatty Acid
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00586222
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2012-01-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00586222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00586222, "Omega 3 Fatty Acid Trial". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT00586222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*